Abstract
Vitamin K antagonists reduce the risk of stroke in patients with atrial fibrillation but are considered unsuitable in many patients, who usually receive aspirin instead. We investigated the hypothesis that the addition of clopidogrel to aspirin would reduce the risk of vascular events in patients with atrial fibrillation.
Original language | English |
---|---|
Pages (from-to) | 2066-78 |
Number of pages | 13 |
Journal | New England Journal of Medicine |
Volume | 360 |
Issue number | 20 |
DOIs | |
Publication status | Published - 2009 |